Thought Leadership - Manatt, Phelps & Phillips, LLP

Manatt Represents A.G.P. in Chromocell Therapeutics Corp. $6.6M IPO

A Manatt team led by Capital Markets Partner Thomas J. Poletti represented Alliance Global Partners (A.G.P.) as the underwriter for Chromocell Therapeutics Corp.@s initial public offering (IPO), which raised $6.6 million. Chromocell Therapeutics, a company based in New Jersey, develops and sells non-opioid and non-addictive treatments for pain and other related medical conditions. Their IPO...

Manatt Represents Ennov in Acquisition of Calyx’s Enterprise Technology Division

A Manatt team, led by Venture Capital and Emerging Companies Partners Richard G.J. McDerby and Michel C. Narganes, along with Corporate and Finance Associate Adriana M. Bass, represented Ennov SAS in their acquisition of the...

What Growth Companies Should Know About The Newly-Broken FTC Deadlock

The latest appointment to the Federal Trade Commission could lead to greater antitrust enforcement in industries that President Biden previously identified in his 2021 executive order regarding competition.

Antitrust, Federal Trade Commission, Mergers, Competition

Manatt Represents Gamelancer, Inc., in Its Sale to Wondr Gaming Corp.

A Manatt team represented Gamelancer, Inc., currently the largest online gaming platform on TikTok and Snapchat with more than 26.5 million followers, in its sale to Wondr Gaming Corp., a publicly traded entertainment company on the Canadian Securities Exchange.

Manatt Represents Life Science Solutions Provider Delta Project Management in its Sale to Verista

A Manatt team represented Delta Project Management, a leading provider of regulatory compliance and project management solutions to the life science industries, in its sale to Verista, a life science business and technology consultancy.

Manatt Represents Vectura Group in Its $11M Pre-Merger Financing With EnBiotix

Manatt represented Vectura Group, a British pharmaceutical company focused on inhaled therapeutics, in its $11 million pre-merger convertible note financing with EnBiotix, a late-clinical stage rare disease biotechnology company focused on chronic respiratory disorders.

Updated: HSR Thresholds Revised (and Lowered) and Early Terminations Suspended Pending Review

On February 1, 2021, the FTC announced revised notification thresholds for determining whether companies or other entities are required to provide notice to the federal antitrust agencies about a proposed transaction under the HSR Act of 1976, as amended.

SEC Makes Key Changes to Accredited Investor Definition

In its Final Rule issued on August 26, 2020, a divided Securities and Exchange Commission (SEC) expanded the group of individuals and entities permitted to invest in private securities by amending the definitions of “accredited investor” and “qualified institutional buyer.”

Founder’s Stock: Vesting and Acceleration

Founder’s stock refers to the equity granted, typically in the form of common stock, to founders of a company for their preformation efforts in building the company.

Tax, Equity, Stock, Founder, Vesting, Common Stock, Acceleration

Selecting the Appropriate Structure for Your Startup

Founders must contend with many important decisions early in the life of a startup, including selecting the appropriate corporate structure.

Investment, Corporate Structure, C Corporation, S Corporation, LLC, Limited Liability Company, Incorporation, Founder, Formation